Sign in to view content

ADVM-022 Intravitreal Gene Therapy for Neovascular AMD: Phase 1 OPTIC Trial Update

Dante Joseph Pieramici, MD

Video
Published 2022

Related

Modeling the Effect of Longer-Acting Drugs and Reimbursement Changes
Robert A Diamond, BBA
Updates from the Field
2022
Episode 155: Argus II Quality of Life Improvements and More with Dr. Jacque Duncan
Jayanth Sridhar, MD
Member Podcasts
2018
Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more